Mesenchymal Stem Cells Market Size & CAGR (2023-2031)
The Mesenchymal Stem Cells Market is expected to register a CAGR of 13.0% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by By Type (Autologous, Allogeneic); Source (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal liver, Lung, Adipose tissues); Indication (Bone and cartilage repair, Cardiovascular disease, Inflammatory and immunological diseases, Liver diseases, Cancer, GvHD); Application (Disease modeling, Drug development and discovery, Stem cell banking, Tissue engineering, Toxicology studies)
The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
The report Mesenchymal Stem Cells Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Mesenchymal Stem Cells Market Segmentation
Type- Autologous
- Allogeneic
- Bone Marrow
- Cord Blood
- Peripheral Blood
- Fallopian Tube
- Fetal liver
- Lung
- Adipose tissues
- Disease modeling
- Drug development and discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Mesenchymal Stem Cells Market Growth Drivers- New demand for Regenerative Medicine: Increased attention toward the regenerative medicine has become an important factor of Mesenchymal cell growth in number. The new therapeutic dimension, which is a prime area of research for the potential power of MSC to regenerate tissues and organs, such as osteoarthritis, cardiovascular diseases, and neurological disorders, will increase the demand for the therapies based on MSC both in the clinical and research framework.Advancements in Stem Cell Research:
The recent advances in the stem cell biology field, especially in understanding MSC differentiation and their therapeutic application, are driving the market. Researchers are bringing to light applications of MSCs in immune modulation, tissue repair, and anti-inflammatory therapies, which are generating rapid clinical adoption of MSC-based treatments for a variety of diseases.Growing Incidence of Chronic Diseases
The various chronic conditions, such as osteoarthritis, heart diseases, and autoimmune disorders, are a major reason behind the surging demand for MSC therapies. Due to these benefits of MSCs in tissue repair and immune system regulation that may eventually put an end to the brutal disease process, this has thereby created an alternative to traditional treatment methods and spurred market growth.
- Increasing Focus on Cell-Based Therapies:
There will be growth in the further development of cell-based therapies for chronic and degenerative diseases that utilize MSCs for the repair and regeneration of damaged tissues. This will be complemented by more clinical trials, partnerships among biotech companies, and advancements in manufacturing processes that would advance the commercial viability of MSCs.Manufacturing of Off-the-Shelf MSC Products
Off-the-shelf, allogeneic MSC products appear to be receiving increasing acceptance. The benefits these allogeneic products offer over autologous therapies are greater convenience and cost-effectiveness to the patient because no cells need to be extracted from the patient. As time progresses and production techniques continue to advance, off-the-shelf MSC products become ever more attainable and deployed to clinical use.Integration with Gene Editing and Immunotherapy
There is a growing pattern to combine MSC-based therapies with gene editing technologies, such as CRISPR, and immunotherapies with additional therapeutic value. This is currently being applied in genetic alterations of MSCs or in the use of immune checkpoint inhibitors for superior responses to numerous therapies, including cancer and autoimmune diseases.
- Neurological Disorders
Neurological disorders, such as Alzheimer's, Parkinson's, and spinal cord injuries, are one of the few treatment opportunities presented in MSCs markets. MSCs have been shown to have the ability to reduce inflammation, promote tissue regeneration, and possibly even cross the blood-brain barrier, which creates much excitement for filling unmet medical needs in neurology.Personalized Regenerative Medicine:
This will provide room for the development of patient-specific MSC therapies. With individualized MSC treatments based on genetic profiles and disease conditions, it will increase the efficiency of the treatment minus side effects; hence, MSCs are likely to play an essential role in personalized care.Growing demand for cosmetic and anti-aging treatments:
These cells have gained significant importance in aesthetic medicine, more particularly in treatments for anti-aging as well as for skin regeneration. Since these cells trigger the synthesis of collagen and enable repairing tissues, MSCs bring great opportunities in cosmetic markets and fields of dermatology - wrinkle reduction and rejuvenation of the skin, for instance.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Mesenchymal Stem Cells Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Mesenchymal Stem Cells Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asia Pacific region dominated the Mesenchmal Stem Cells Market in 2023
The market is expected to grow at a CAGR of 10.2%
The Mesenchymal Stem Cells Market is estimated to witness a CAGR of 13.0% from 2023 to 2031
North America region dominated the Mesenchmal Stem Cells Market in 2023
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Cell Applications, Inc. Axol Biosciences Ltd. Cytori Therapeutics Inc.STEMCELL Technologies Inc.,Cyagen Biosciences Inc. Celprogen Inc.BrainStorm Cell Therapeutics Inc. Stemedica Cell Technologies Inc. Merck KGaA (MilliporeSigma)
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mesenchymal Stem Cells Market - By Type
1.3.2 Mesenchymal Stem Cells Market - By Source
1.3.3 Mesenchymal Stem Cells Market - By Indication
1.3.4 Mesenchymal Stem Cells Market - By Application
1.3.5 Mesenchymal Stem Cells Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MESENCHYMAL STEM CELLS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. MESENCHYMAL STEM CELLS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MESENCHYMAL STEM CELLS MARKET - GLOBAL MARKET ANALYSIS
6.1. MESENCHYMAL STEM CELLS - GLOBAL MARKET OVERVIEW
6.2. MESENCHYMAL STEM CELLS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MESENCHYMAL STEM CELLS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS
7.3.1. Overview
7.3.2. Autologous Market Forecast and Analysis
7.4. ALLOGENEIC
7.4.1. Overview
7.4.2. Allogeneic Market Forecast and Analysis
8. MESENCHYMAL STEM CELLS MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
8.1. OVERVIEW
8.2. SOURCE MARKET FORECASTS AND ANALYSIS
8.3. BONE MARROW
8.3.1. Overview
8.3.2. Bone Marrow Market Forecast and Analysis
8.4. CORD BLOOD
8.4.1. Overview
8.4.2. Cord Blood Market Forecast and Analysis
8.5. PERIPHERAL BLOOD
8.5.1. Overview
8.5.2. Peripheral Blood Market Forecast and Analysis
8.6. FALLOPIAN TUBE
8.6.1. Overview
8.6.2. Fallopian Tube Market Forecast and Analysis
8.7. FETAL LIVER
8.7.1. Overview
8.7.2. Fetal liver Market Forecast and Analysis
8.8. LUNG
8.8.1. Overview
8.8.2. Lung Market Forecast and Analysis
8.9. ADIPOSE TISSUES
8.9.1. Overview
8.9.2. Adipose tissues Market Forecast and Analysis
9. MESENCHYMAL STEM CELLS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. BONE AND CARTILAGE REPAIR
9.3.1. Overview
9.3.2. Bone and cartilage repair Market Forecast and Analysis
9.4. CARDIOVASCULAR DISEASE
9.4.1. Overview
9.4.2. Cardiovascular disease Market Forecast and Analysis
9.5. INFLAMMATORY AND IMMUNOLOGICAL DISEASES
9.5.1. Overview
9.5.2. Inflammatory and immunological diseases Market Forecast and Analysis
9.6. LIVER DISEASES
9.6.1. Overview
9.6.2. Liver diseases Market Forecast and Analysis
9.7. CANCER
9.7.1. Overview
9.7.2. Cancer Market Forecast and Analysis
9.8. GVHD
9.8.1. Overview
9.8.2. GvHD Market Forecast and Analysis
10. MESENCHYMAL STEM CELLS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. DISEASE MODELING
10.3.1. Overview
10.3.2. Disease modeling Market Forecast and Analysis
10.4. DRUG DEVELOPMENT AND DISCOVERY
10.4.1. Overview
10.4.2. Drug development and discovery Market Forecast and Analysis
10.5. STEM CELL BANKING
10.5.1. Overview
10.5.2. Stem cell banking Market Forecast and Analysis
10.6. TISSUE ENGINEERING
10.6.1. Overview
10.6.2. Tissue engineering Market Forecast and Analysis
10.7. TOXICOLOGY STUDIES
10.7.1. Overview
10.7.2. Toxicology studies Market Forecast and Analysis
11. MESENCHYMAL STEM CELLS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Mesenchymal Stem Cells Market Overview
11.1.2 North America Mesenchymal Stem Cells Market Forecasts and Analysis
11.1.3 North America Mesenchymal Stem Cells Market Forecasts and Analysis - By Type
11.1.4 North America Mesenchymal Stem Cells Market Forecasts and Analysis - By Source
11.1.5 North America Mesenchymal Stem Cells Market Forecasts and Analysis - By Indication
11.1.6 North America Mesenchymal Stem Cells Market Forecasts and Analysis - By Application
11.1.7 North America Mesenchymal Stem Cells Market Forecasts and Analysis - By Countries
11.1.7.1 United States Mesenchymal Stem Cells Market
11.1.7.1.1 United States Mesenchymal Stem Cells Market by Type
11.1.7.1.2 United States Mesenchymal Stem Cells Market by Source
11.1.7.1.3 United States Mesenchymal Stem Cells Market by Indication
11.1.7.1.4 United States Mesenchymal Stem Cells Market by Application
11.1.7.2 Canada Mesenchymal Stem Cells Market
11.1.7.2.1 Canada Mesenchymal Stem Cells Market by Type
11.1.7.2.2 Canada Mesenchymal Stem Cells Market by Source
11.1.7.2.3 Canada Mesenchymal Stem Cells Market by Indication
11.1.7.2.4 Canada Mesenchymal Stem Cells Market by Application
11.1.7.3 Mexico Mesenchymal Stem Cells Market
11.1.7.3.1 Mexico Mesenchymal Stem Cells Market by Type
11.1.7.3.2 Mexico Mesenchymal Stem Cells Market by Source
11.1.7.3.3 Mexico Mesenchymal Stem Cells Market by Indication
11.1.7.3.4 Mexico Mesenchymal Stem Cells Market by Application
11.2. EUROPE
11.2.1 Europe Mesenchymal Stem Cells Market Overview
11.2.2 Europe Mesenchymal Stem Cells Market Forecasts and Analysis
11.2.3 Europe Mesenchymal Stem Cells Market Forecasts and Analysis - By Type
11.2.4 Europe Mesenchymal Stem Cells Market Forecasts and Analysis - By Source
11.2.5 Europe Mesenchymal Stem Cells Market Forecasts and Analysis - By Indication
11.2.6 Europe Mesenchymal Stem Cells Market Forecasts and Analysis - By Application
11.2.7 Europe Mesenchymal Stem Cells Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Mesenchymal Stem Cells Market
11.2.7.1.1 Germany Mesenchymal Stem Cells Market by Type
11.2.7.1.2 Germany Mesenchymal Stem Cells Market by Source
11.2.7.1.3 Germany Mesenchymal Stem Cells Market by Indication
11.2.7.1.4 Germany Mesenchymal Stem Cells Market by Application
11.2.7.2 France Mesenchymal Stem Cells Market
11.2.7.2.1 France Mesenchymal Stem Cells Market by Type
11.2.7.2.2 France Mesenchymal Stem Cells Market by Source
11.2.7.2.3 France Mesenchymal Stem Cells Market by Indication
11.2.7.2.4 France Mesenchymal Stem Cells Market by Application
11.2.7.3 Italy Mesenchymal Stem Cells Market
11.2.7.3.1 Italy Mesenchymal Stem Cells Market by Type
11.2.7.3.2 Italy Mesenchymal Stem Cells Market by Source
11.2.7.3.3 Italy Mesenchymal Stem Cells Market by Indication
11.2.7.3.4 Italy Mesenchymal Stem Cells Market by Application
11.2.7.4 Spain Mesenchymal Stem Cells Market
11.2.7.4.1 Spain Mesenchymal Stem Cells Market by Type
11.2.7.4.2 Spain Mesenchymal Stem Cells Market by Source
11.2.7.4.3 Spain Mesenchymal Stem Cells Market by Indication
11.2.7.4.4 Spain Mesenchymal Stem Cells Market by Application
11.2.7.5 United Kingdom Mesenchymal Stem Cells Market
11.2.7.5.1 United Kingdom Mesenchymal Stem Cells Market by Type
11.2.7.5.2 United Kingdom Mesenchymal Stem Cells Market by Source
11.2.7.5.3 United Kingdom Mesenchymal Stem Cells Market by Indication
11.2.7.5.4 United Kingdom Mesenchymal Stem Cells Market by Application
11.2.7.6 Rest of Europe Mesenchymal Stem Cells Market
11.2.7.6.1 Rest of Europe Mesenchymal Stem Cells Market by Type
11.2.7.6.2 Rest of Europe Mesenchymal Stem Cells Market by Source
11.2.7.6.3 Rest of Europe Mesenchymal Stem Cells Market by Indication
11.2.7.6.4 Rest of Europe Mesenchymal Stem Cells Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Mesenchymal Stem Cells Market Overview
11.3.2 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis
11.3.3 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis - By Source
11.3.5 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Mesenchymal Stem Cells Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Mesenchymal Stem Cells Market
11.3.7.1.1 Australia Mesenchymal Stem Cells Market by Type
11.3.7.1.2 Australia Mesenchymal Stem Cells Market by Source
11.3.7.1.3 Australia Mesenchymal Stem Cells Market by Indication
11.3.7.1.4 Australia Mesenchymal Stem Cells Market by Application
11.3.7.2 China Mesenchymal Stem Cells Market
11.3.7.2.1 China Mesenchymal Stem Cells Market by Type
11.3.7.2.2 China Mesenchymal Stem Cells Market by Source
11.3.7.2.3 China Mesenchymal Stem Cells Market by Indication
11.3.7.2.4 China Mesenchymal Stem Cells Market by Application
11.3.7.3 India Mesenchymal Stem Cells Market
11.3.7.3.1 India Mesenchymal Stem Cells Market by Type
11.3.7.3.2 India Mesenchymal Stem Cells Market by Source
11.3.7.3.3 India Mesenchymal Stem Cells Market by Indication
11.3.7.3.4 India Mesenchymal Stem Cells Market by Application
11.3.7.4 Japan Mesenchymal Stem Cells Market
11.3.7.4.1 Japan Mesenchymal Stem Cells Market by Type
11.3.7.4.2 Japan Mesenchymal Stem Cells Market by Source
11.3.7.4.3 Japan Mesenchymal Stem Cells Market by Indication
11.3.7.4.4 Japan Mesenchymal Stem Cells Market by Application
11.3.7.5 South Korea Mesenchymal Stem Cells Market
11.3.7.5.1 South Korea Mesenchymal Stem Cells Market by Type
11.3.7.5.2 South Korea Mesenchymal Stem Cells Market by Source
11.3.7.5.3 South Korea Mesenchymal Stem Cells Market by Indication
11.3.7.5.4 South Korea Mesenchymal Stem Cells Market by Application
11.3.7.6 Rest of Asia-Pacific Mesenchymal Stem Cells Market
11.3.7.6.1 Rest of Asia-Pacific Mesenchymal Stem Cells Market by Type
11.3.7.6.2 Rest of Asia-Pacific Mesenchymal Stem Cells Market by Source
11.3.7.6.3 Rest of Asia-Pacific Mesenchymal Stem Cells Market by Indication
11.3.7.6.4 Rest of Asia-Pacific Mesenchymal Stem Cells Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Mesenchymal Stem Cells Market Overview
11.4.2 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis
11.4.3 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis - By Source
11.4.5 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Mesenchymal Stem Cells Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Mesenchymal Stem Cells Market
11.4.7.1.1 South Africa Mesenchymal Stem Cells Market by Type
11.4.7.1.2 South Africa Mesenchymal Stem Cells Market by Source
11.4.7.1.3 South Africa Mesenchymal Stem Cells Market by Indication
11.4.7.1.4 South Africa Mesenchymal Stem Cells Market by Application
11.4.7.2 Saudi Arabia Mesenchymal Stem Cells Market
11.4.7.2.1 Saudi Arabia Mesenchymal Stem Cells Market by Type
11.4.7.2.2 Saudi Arabia Mesenchymal Stem Cells Market by Source
11.4.7.2.3 Saudi Arabia Mesenchymal Stem Cells Market by Indication
11.4.7.2.4 Saudi Arabia Mesenchymal Stem Cells Market by Application
11.4.7.3 U.A.E Mesenchymal Stem Cells Market
11.4.7.3.1 U.A.E Mesenchymal Stem Cells Market by Type
11.4.7.3.2 U.A.E Mesenchymal Stem Cells Market by Source
11.4.7.3.3 U.A.E Mesenchymal Stem Cells Market by Indication
11.4.7.3.4 U.A.E Mesenchymal Stem Cells Market by Application
11.4.7.4 Rest of Middle East and Africa Mesenchymal Stem Cells Market
11.4.7.4.1 Rest of Middle East and Africa Mesenchymal Stem Cells Market by Type
11.4.7.4.2 Rest of Middle East and Africa Mesenchymal Stem Cells Market by Source
11.4.7.4.3 Rest of Middle East and Africa Mesenchymal Stem Cells Market by Indication
11.4.7.4.4 Rest of Middle East and Africa Mesenchymal Stem Cells Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Mesenchymal Stem Cells Market Overview
11.5.2 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis
11.5.3 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis - By Type
11.5.4 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis - By Source
11.5.5 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis - By Application
11.5.7 South and Central America Mesenchymal Stem Cells Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Mesenchymal Stem Cells Market
11.5.7.1.1 Brazil Mesenchymal Stem Cells Market by Type
11.5.7.1.2 Brazil Mesenchymal Stem Cells Market by Source
11.5.7.1.3 Brazil Mesenchymal Stem Cells Market by Indication
11.5.7.1.4 Brazil Mesenchymal Stem Cells Market by Application
11.5.7.2 Argentina Mesenchymal Stem Cells Market
11.5.7.2.1 Argentina Mesenchymal Stem Cells Market by Type
11.5.7.2.2 Argentina Mesenchymal Stem Cells Market by Source
11.5.7.2.3 Argentina Mesenchymal Stem Cells Market by Indication
11.5.7.2.4 Argentina Mesenchymal Stem Cells Market by Application
11.5.7.3 Rest of South and Central America Mesenchymal Stem Cells Market
11.5.7.3.1 Rest of South and Central America Mesenchymal Stem Cells Market by Type
11.5.7.3.2 Rest of South and Central America Mesenchymal Stem Cells Market by Source
11.5.7.3.3 Rest of South and Central America Mesenchymal Stem Cells Market by Indication
11.5.7.3.4 Rest of South and Central America Mesenchymal Stem Cells Market by Application
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. MESENCHYMAL STEM CELLS MARKET, KEY COMPANY PROFILES
13.1. CELL APPLICATIONS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AXOL BIOSCIENCES LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CYTORI THERAPEUTICS INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. STEMCELL TECHNOLOGIES INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CYAGEN BIOSCIENCES INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CELPROGEN INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BRAINSTORM CELL THERAPEUTICS INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. STEMEDICA CELL TECHNOLOGIES INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERCK KGAA (MILLIPORESIGMA)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SMITH AND NEPHEW
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. LONZA AG
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. PROMOCELL GMBH
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. THERMO FISHER SCIENTIFIC
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1.Cell Applications, Inc.
2.Axol Biosciences Ltd.
3.Cytori Therapeutics Inc
4.STEMCELL Technologies Inc
5.Cyagen Biosciences Inc.
6.Celprogen Inc
7.BrainStorm Cell Therapeutics Inc.
8.Stemedica Cell Technologies Inc
9.Merck KGaA (MilliporeSigma)
10.Smith and Nephew
11.Lonza AG
12.PromoCell GmbH
13.Thermo Fisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For